Predicting Platelet Count From Viscoelastic Testing
NCT06870851 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500
Last updated 2025-03-11
Summary
Viscoelastic testing is a highly recommended cornerstone of modern coagulation medicine, reducing transfusion needs. A disadvantage of viscoelastic tests is the impossibility of making a definitive statement about the platelet count.
Therefore, the aim of this retrospective observational study is, on the one hand, to predict the platelet count based on standard ROTEM parameters with the help of several machine learning methods and, on the other hand, to detect a low platelet count ( \<100000 ml-1 and \< 50000 ml-1).
Conditions
Sponsors & Collaborators
-
Kepler University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-01
- Primary Completion
- 2025-04-30
- Completion
- 2025-12-31
Countries
- Austria
Study Locations
More Related Trials
-
Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia
NCT07099313 ·Status: RECRUITING
-
Study of Biostate® in Children With Hemophilia A
NCT01229007 ·Status: COMPLETED ·Phase: PHASE3
-
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
NCT02061033 ·Status: UNKNOWN
-
Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation
NCT00375323 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry
NCT03603275 ·Status: TERMINATED
-
Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B
NCT01220141 ·Status: COMPLETED
-
Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
NCT00178607 ·Status: COMPLETED
-
Drug Use Investigation of Kovaltry in Hemophilia A Patients
NCT02941783 ·Status: COMPLETED
-
Age-dependency of Thrombin Generation Using a New Standardized Assay
NCT03007108 ·Status: COMPLETED ·Phase: NA
-
Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography
NCT01561924 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.
NCT02246894 ·Status: COMPLETED ·Phase: PHASE3
-
Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders
NCT02324517 ·Status: UNKNOWN
-
Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment
NCT00623480 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Patient and Physician Reported Reasons for Switching Factor VIII Replacement Therapies
NCT03405337 ·Status: COMPLETED
-
Low VW Activity in Adolescent HMB
NCT02933411 ·Status: ACTIVE_NOT_RECRUITING
-
Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa
NCT01856751 ·Status: UNKNOWN
-
Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
NCT00782470 ·Status: COMPLETED
-
Thrombin Generation Numerical Models Validation in Haemophilic Case
NCT02300519 ·Status: COMPLETED
-
Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens
NCT00927667 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.
NCT04405518 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
NCT02830477 ·Status: COMPLETED
-
Viscoelastic Properties of Lower Extremity Muscles in Patients With Hemophilia
NCT05981313 ·Status: UNKNOWN
-
Interference by Activated Protein C Resistance in the Determination of Protein S Activity
NCT06182501 ·Status: RECRUITING
-
Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease
NCT07273721 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of a Kit for the Prediction of the Risk of Graft Versus Host Disease
NCT02751112 ·Status: TERMINATED ·Phase: NA